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Methods: Clinical and histopathological case series.
Results: Amyloid subepithelial deposition was found in 5 (6.6%) corneal buttons of 75 patients
with histopathologically conﬁrmed CHED diagnosis. Clinical ﬁndings included history of parental
consanguinity, poor vision (ranging from counting ﬁngers from one foot to 3/200), corneal edema,
and central whitish subepithelial corneal nodules in all the ﬁve cases and positive family history in 4
of 5 cases. The patients underwent PKP at a mean age of 15 years (range 3–22 years). Histological
ﬁndings included attenuated endothelium (6/6) thickened Descemet’s membrane (6/6), stromal
edema (2/6), and subepithelial amyloid deposits (6/6). All patients improved from vision point of
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112 A. Al-Shehah et al.Conclusion: Considering the consanguinity, family history, early onset, and bilaterality, this study
supports our hypothesis that the amyloid is primary in nature in our patients and indicates a new
subtype of autosomal recessive CHED that require further chemical and genetic analysis. This sub-
type has the same prognosis for PKP as all CHED patients, if not better.
ª 2010 King Saud University. All rights reserved.1. Introduction
Congenital hereditary endothelial dystrophy (CHED) presents
at or shortly after birth with bilateral corneal edema. This cor-
neal disorder can be inherited in an autosomal dominant or
recessive form. The pathology of CHED is attributed to endo-
thelial cells degeneration during gestation (Maumenee, 1960;
Pearce et al., 1969; Kenyon and Antine, 1971; Judisch and
Maumenee, 1978).
Cornea is a known ocular site for amyloid deposition either
as primary or secondary pathology. Primary corneal amyloid
deposition (amyloid AL) can be seen in lattice corneal dystro-
phy, polymorphic amyloid degeneration (PAD), and gelati-
nous drop-like corneal dystrophy. Secondary corneal
amyloid deposition (amyloid AA) is most frequently associ-
ated with local eye disease such as uveitis, ocular trauma,
CDK, ROP, keratoconus, trichiasis, and trachoma (Nagataki
et al., 1972; Stern et al., 1988; Hidayat and Risco, 1989; Aso
and Wakakura, 2000; Matta et al., 1991; Hill et al., 1990).
Two recent studies addressed the association of corneal
amyloid deposition with congenital hereditary amyloid dystro-
phy (Mahmood and Teichmann, 2000; Vemuganti et al., 2002).
Amyloid deposition was postulated to be possibly primary in
nature in association with CHED by Mahmood and
Teichmann (2000). While Vemuganti et al. concluded that this
association was secondary in nature (Vemuganti et al., 2002).
In this study we evaluated the clinical and histopathological
ﬁndings in ﬁve patients with CHED associated with subepithe-
lial amyloid deposition.2. Materials and methods
Corneal buttons pathology reports of 86 patients with CHED
who underwent PKP from 1983 to 2006 at King Khalid eye
specialist hospital (KKESH) were reviewed for presence or ab-
sence of amyloid. Histopathology slides of corneal buttons re-
ported to have amyloid deposits as well as histopathology
slides unclearly or insufﬁciently reported were reviewed by a
single pathologist at KKESH to determine the presence of
deposits and details of the amyloid distribution. Out of 86
operated CHED patients at KKESH, 75 patients had histopa-
thology slides available from one or both eyes. Therefore, 11
patients were excluded. Out of the 75 patients, ﬁve patients
only had amyloid deposition in association with CHED.
The corresponding clinical and demographic data of all
CHED patients with corneal amyloid deposition were re-
viewed for clinico-pathologic correlation and analysis. We
identiﬁed ﬁve patients (six corneal buttons) with subepithelial
amyloid deposits. Corneal buttons from relatives of those ﬁve
patients who had PKP for CHED at KKESH were also re-
viewed for the presence or absence of amyloid and were all
negative.All ﬁve patients (eight eyes) underwent PKP while they
were receiving general anesthesia. The trephine size was
6.75 mm in one eye, and 7 mm in seven eyes in the recipient
cornea, although the donor corneal trephine size was larger
by 0.25 mm in four eyes, and 0.5 mm in the other four eyes.
The sutures were continuous in two eyes, interrupted in ﬁve
eyes, and combined in one eye. Sutures were removed com-
pletely in a mean time of 13.5 months (range, 3–44 months).
Patients were followed up for a mean of 112 months (range,
10–264 months).
Parafﬁn sections were prepared from six corneal buttons
after overnight 10% formalin ﬁxation, stained with Hematox-
ylin and Eosin (H&E), Periodic Acid-Schiff (PAS) and Congo
red stains. Two corneal buttons from two different patients
(patients 4 and 5) were submitted only for electron microscopy
studies and no histopathology slides were prepared.3. Results
Five patients (out of 75) were found to have subepithelial
amyloid deposition (6.6%). The age of the ﬁve patients at
the time of PKP ranged from 3 to 22 years (mean, 15 years);
there were three females and two males. Four patients were
all members of one Saudi family and one patient (patient 1)
was Yemeni. The clinical features of these patients are sum-
marized in Table 1. History of consanguinity was positive in
all cases. The clinical diagnosis of CHED was made in all
cases. Patient 1 had relatively good visual acuity in the left
eye (20/100) for which PKP was not performed in that eye.
Patient 2 was already grafted in the right eye 3 years earlier
on presentation to KKESH and the patient had a pathology
report documenting the diagnosis of CHED along with the
presence of subepithelial amyloid deposits, but obtaining
slides from original corneal button was not possible. Later
on that right graft failed and we performed another PKP
but we did not ﬁnd any evidence of CHED recurrence nor
amyloid deposition in that failed graft. Patients 4 and 5 entire
left corneal buttons were submitted for Electron Microscopy
studies which conﬁrmed the clinical diagnosis of CHED as
part of another ongoing prospective study concerning CHED
but the gold stain used on those buttons precluded the possi-
bility of amyloid identiﬁcation by histopathology, neverthe-
less, both left eyes for both patient contained clinically the
same white nodular subepithelial pathology proven to be
amyloid in the contralateral eyes by histopathology (Figs. 1
and 2).
No graft rejection episodes were documented in any of the
patients. Patient 3 had left graft failure 30 months after the pri-
mary graft that was not caused by neither rejection nor infec-
tion. This failed graft got infected 5 months later (treated
elsewhere) and another PKP was performed 72 months after
performing the primary graft. The secondary graft failed as
well and a third PKP was performed 49 months later. The
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Figure 1 Patient 4, central grayish-white nodular subepithelial
elevation in right eye.
Figure 2 Patient 4, same focal nodules observed in the contra-
lateral eye.
Amyloid corneal deposition in corneal buttons of congenital hereditary endothelial dystrophy (CHED) 113tertiary graft remains clear. Apart from patient 3 left graft,
none of the remaining grafts (including patient 3 right graft)
were infected nor labeled as failed. Vision in all eyes improved.
Histopathology features of these six corneal buttons are
presented in Table 2. Amyloid deposits noted in six corneal
buttons were subepithelial (patient 4 had even deeper amyloid
deposits involving the mid-stroma) which appeared as amor-
phous plaque-like nodules (Figs. 3, 5–7) with characteristic
birefringence under polarized light microscopy (Fig. 4). Bow-
man’s layer was either absent (in two patients) or interrupted
(in four patients). The stromal edema (thickening) was evident
in only two patients (patients #2 and 5) but without stromal
scarring. Anterior or Mid-stromal neovascularization was evi-
dent in the ﬁrst four patients. Stromal inﬂammation was seen
in all but one patient (#4). Descemet’s membrane was thick-
ened in all patients. The endothelium was attenuated in all pa-
tients as well.
4. Discussion
Starch (amylum in Latin) was mistakenly thought to be the
substance forming amyloid based on crude iodine-staining
Figure 3 Patient 4, the corresponding corneal subepithelial
amyloid nodule (arrow) reaching the mid-stroma of the right eye
in the previous patient (Congo red stain; original magniﬁcation
200·).
Figure 4 Patient 3, the subepithelial deposits exhibit birefrin-
gence with polarized light conﬁrming the presence of amyloid
(Congo red stain; original magniﬁcation 100·).
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114 A. Al-Shehah et al.techniques, until it was ﬁnally resolved that it was rather a
deposition of proteinaceous mass (Kyle, 2001). The classical,
histopathological deﬁnition of amyloid is an extracellular, pro-
teinaceous deposit exhibiting cross-beta structure due to
mis-folding of unstable proteins. These deposits are generally
identiﬁed by apple-green birefringence when stained with Con-
go red and seen under polarized light. They often recruit var-
ious sugars and other components such as serum Amyloid P
component, resulting in complex, and sometimes inhomoge-
neous structures (Sipe and Cohen, 2000).
There are at least two types of amyloid. Type A (known
also as AA) is a non-immunoglobulin protein of unknown ori-
gin. Type B amyloid has been shown to be identical to a frag-
ment of light chain of immunoglobulin. Amyloid deposits are
associated with a structural protein known as P or AP (Spark
et al., 1978). The deposition of amyloid in various body tissues
Figure 5 Patient 1, OD. Corneal subepithelial amyloid (Congo
red stain; original magniﬁcation 100·).
Figure 6 Patient 2, OD. Corneal subepithelial amyloid (Congo
red stain; original magniﬁcation 100·).
Figure 7 Patient 5, OD. Corneal subepithelial amyloid (Congo
red stain; original magniﬁcation 200·).
Amyloid corneal deposition in corneal buttons of congenital hereditary endothelial dystrophy (CHED) 115results in amyloidosis and the reason for it is unknown. It may
be a disorder of protein metabolism or hypersensitivity, an
abnormality of reticular endothelial system, the result of
chronic immunologic reaction, or a combination of these de-
fects (Scheinberg and Cathcart, 1974).
Amyloidosis is a heterogeneous group of disorders in which
ﬁbrillar hyaline proteins including amyloid P protein (AP),
prealbumin or transthyretin (AF), immunoglobulin light
chains (AL), and acute phase reactants (AA) are deposited in
a variety of target tissue (Blodi and Apple, 1979).
Amyloidosis can be classiﬁed into systemic and localized.
Systemic amyloidosis can be primary or secondary. Primary
systemic type usually involves the tongue (macroglossia), heart
(cardiomyopathy), GIT (malabsorption), peripheral nerves
(neuropathy including ptosis), kidney (nephrotic syndrome),
ocular muscles (ophthalmoplegia), vitrouse, and cornea (Mere-
toja syndrome or lattice corneal dystrophy type II) (Meretoja,
1969, 1973). Secondary systemic amyloidosis is usually found
in association with malignancies, tuberculosis, rheumatoid
arthritis, syphilis, and other chronic inﬂammatory conditions
and it is the most commonly encountered form McPherson
(1966).
In primary amyloid deposition (AL) the amyloid ﬁbrils con-
sist of the variable portions of monoclonal kappa (j) or lamb-
da (k) immunoglobulin light chains. In secondary amyloid
deposition (AA) the amyloid ﬁbrils consist of protein A, a
non-immunoglobulin (Meretoja, 1969, 1973; McPherson,
1966).
Cornea is a frequent ocular site for amyloid deposition
either as primary or secondary pathology. Primary corneal
amyloid deposition (amyloid AL) can be seen in lattice dystro-
phy, polymorphic amyloid degeneration (PAD), and gelati-
nous drop-like corneal dystrophy. Secondary corneal
amyloid deposition (amyloid AA) is most frequently associ-
ated with local eye disease such as uveitis, ocular trauma, cli-
matic droplet keratopathy, retinopathy of prematurity,
keratoconus, trichiasis, and trachoma (Stern et al., 1988; Hid-
ayat and Risco, 1989; Aso and Wakakura, 2000; Matta et al.,
1991; Hill et al., 1990; McPherson, 1966).
Polymorphic amyloid degeneration presents as corneal
punctate and ﬁlamentous opacities that affect patients in their
forth decade or older (Mannis et al., 1981; Woodward et al.,
2007). Family studies failed to demonstrate heritability and
therefore it is classiﬁed as degeneration rather than dystrophy
(Mannis et al., 1981). The deposits are usually in the deeper
layers associated with normal intervening stroma (Mannis
et al., 1981). Although it is not a cause of visual dysfunction,
this disorder (Mannis et al., 1981). It can be associated with
posterior polymorphous corneal dystrophy (Molia et al.,
1999) or posterior crocodile shagreen corneal degeneration
(Woodward et al., 2007).
Lattice corneal dystrophy usually is an autosomal domi-
nant condition, and it is one of the common stromal dys-
trophies. Like granular and Avellino dystrophy, the
genetic defect of lattice dystrophy has been mapped to the
BIG H3 gene on chromosome 5q. Examination of the cor-
nea in the second to third decade of life will reveal stromal
branching, refractile lattice lines representing amyloid pro-
tein with intervening haze, which are observed best in ret-
roillumination. Lattice dystrophy can cause excessive
corneal erosions and decreased visual acuity requiring a cor-
neal transplant or phototherapeutic keratectomy (PTK).
116 A. Al-Shehah et al.Recurrence after keratoplasty is a known complication
(Chan et al., 1982).
Primary gelatinous drop-like corneal dystrophy (PGDD) is
a rare corneal dystrophy, most probably autosomal recessive
in nature and was ﬁrst described in Japan in 1914 followed
by other reports (Nagataki et al., 1972; Akiya et al., 1972;
Santo et al., 1995). It usually presents with photophobia, for-
eign body sensation, and decreased vision in the second or
third decades of life. PGDD has a high incidence of recurrence
after keratoplasty (Santo et al., 1995).
Eyelid skin is another frequent site for amyloid deposition.
Waxy, yellowish appearing small papules are typical. Conjunc-
tival involvement is rather rare in the form of amyloid nodules,
but of importance as it may mimic other forms of conjunctivi-
tis, including trachoma (Blodi and Apple, 1979). Primary
localized amyloid deposition in the orbit (mainly lacrimal
gland and ocular muscles) is rare and can lead to proptosis
(Knowles et al., 1975). Familial amyloidosis can affect the pu-
pil in the form of segmental iris paralysis, pupillary dissocia-
tion with inequality, and heterochromia (Falls et al., 1955).
Amyloid deposits in the vitreous are known to occur in the
systemic familial amyloidosis. Isolated vitreous deposits in the
absence of a family history (primary non-familial amyloidosis
of the vitreous) are extremely rare and may mimic other con-
ditions including vitritis, lymphoma, endophthalmitis and old
vitreous haemorrhage (Bitwas et al., 1992). Glaucoma occur-
ring in association with vitreous amyloidosis is thought to re-
sult from transport of amyloid by the aqueous ﬂuid and its
deposition in the trabecular meshwork (Gregory et al., 1999).
Congenital hereditary endothelial dystrophy (CHED) was
ﬁrst described as ‘‘corneitis interstitialis in utero’’ in 1893 by
Laurence. Initially classiﬁed as an intrauterine interstitial ker-
atitis, then stromal dystrophy (Pearce et al., 1969). In 1960,
Maumenee was the ﬁrst to describe CHED as primary corneal
endothelial dysfunction (Maumenee, 1960). In 1971, the name
Congenital hereditary endothelial dystrophy was suggested by
Kenyon and Antine (1971). The inheritance of the Autosomal-
dominant (AD) type (CHED1) has been linked to chromo-
some 20, near posterior polymorphous dystrophy (PPMD) lo-
cus, while the Autosomal-recessive (AR) type (CHED2) is not
linked to this chromosome, thus indicating a genetically dis-
tinct entity (Al-Rajhi, 2000; Kanis et al., 1999; Shah et al.,
2008).
Congenital hereditary endothelial dystrophy is character-
ized by diffuse, non-inﬂammatory corneal opacities with ede-
ma. The disease is bilateral and tends to be symmetric.
Marked impairment of vision is characteristic. CHED typi-
cally presents at birth or in early infancy as a common cause
of childhood corneal opaciﬁcation.
The two forms of CHED have different clinical characteris-
tics (Judisch and Maumenee, 1978). Children with dominant
CHED have clear corneas at birth with clouding ﬁrst noted
during the ﬁrst or second year of life then slowly progresses
over 5–10 years. Photophobia and epiphora are common and
may be the presenting signs of the disease. Nystagmus is
uncommon and vision tends to be better (in the range of 20/
40 to 20/400) than in recessive CHED. Some authors have sug-
gested that CHEDI is more appropriately termed infantile
hereditary endothelial dystrophy, given its clinical characteris-
tics (Judisch and Maumenee, 1978; Al-Rajhi, 2000). In con-
trast, corneal clouding is present at birth or within the
neonatal period in recessive CHED. Corneal opaciﬁcation isdense at the time of diagnosis, and does not tend to progress.
There is no associated photophobia or epiphora. Nystagmus is
invariably present, presumably as a result of severe corneal
opaciﬁcation at an early age (Judisch and Maumenee, 1978).
CHED has been associated with congenital glaucoma.
Abnormalities in the neural crest could theoretically cause
both entities in a single patient. Because both conditions can
present with corneal opaciﬁcation and edema, accurate diag-
nosis may be difﬁcult and false elevations of intraocular pres-
sure (IOP) caused by stromal edema can compound this
problem. Other clinical characteristics must often be consid-
ered to distinguish the two diseases. For example, progres-
sively enlarging corneal diameter is more characteristic of
congenital glaucoma and corneal edema from congenital glau-
coma should resolve after the IOP is lowered (Mullaney et al.,
1995).
Histopathologic changes in CHED are concentrated in the
endothelium and Descemet’s membrane. The endothelial cells
of the peripheral cornea in CHED have a relatively normal
appearance. The endothelium becomes attenuated in the mid-
periphery and is completely absent from the central cornea. In
the transition zone, cells are irregularly shaped, with pleomor-
phism and polymegathism. The normal hexagonal pattern is
lost. By ultrastructure studies, endothelial organelles are
abnormal, including dilated mitochondria. Descemet’s mem-
brane may be either thickened (Chan et al., 1982) or thinned
(Kirkness et al., 1987) in CHED, possibly related to the degree
and timing of endothelial dysfunction (Moller-Pedersen, 1997).
Thinned or attenuated Descemet’s membrane may be the se-
quel of endothelial dysfunction in utero, so that only the fetal
anterior banded zone is produced. Thickened Descemet’s
membrane, on the other hand, is the result of persistent dystro-
phic or dysfunctional endothelium that secretes a reactive pos-
terior collagenous layer or an exaggerated, but structurally
normal, posterior non-banded layer (Moller-Pedersen, 1997).
Finally the corneal endothelial permeability is signiﬁcantly in-
creased, as is expected with a dysfunctional endothelial barrier
(Chan et al., 1982). Progressive stromal and epithelial edema
occur later accompanied by secondary structural changes.
The normal appearance of the anterior banded zone of Desc-
emet’s membrane suggests that the endothelium is most likely
functionally normal up to the ﬁfth month in utero (Chan et al.,
1982; Moller-Pedersen, 1997). Degeneration starting with the
central cornea occurs thereafter which is believed to arise from
an abnormality in the terminal differentiation of neural crest
cells (Mullaney et al., 1995).
Penetrating keratoplasty is currently the best option for vi-
sual rehabilitation and remains the most acceptable form of
management with good results (Vemuganti et al., 2002). Cor-
neal transplantation for CHED has a better prognosis than
do other pediatric indications because these eyes typically lack
corneal neovascularization, inﬂammation, and concomitant
intraocular pathology (Dana et al., 1995). One series have
demonstrated a 90% graft survival rate in CHED with a mean
follow-up of approximately 3 years (Sajjadi et al., 1995). The
autosomal dominant type is associated with relatively better vi-
sion due to later onset and lack of nystagmus (Kenyon and
Antine, 1971; Judisch and Maumenee, 1978). In Saudi Arabia,
a previous study has shown the graft survival rate to be higher
in delayed-onset CHED (96%) than in CHED present at birth
(56%) (Al-Rajhi and Wagoner, 1997). Pediatric penetrating
keratoplasty poses greater technical challenges and, in general,
Amyloid corneal deposition in corneal buttons of congenital hereditary endothelial dystrophy (CHED) 117is less successful than corneal transplantation in adults (Frueh
and Brown, 1997). Effective visual rehabilitation in patients
with CHED is time-consuming for parents, child, and surgeon.
Aggressive amblyopia management is critical for optimal vi-
sual recovery (Sajjadi et al., 1995; Frueh and Brown, 1997).
In our current study we are presenting the clinical and his-
tologic features of the association of CHED and Amyloid
corneal deposition. The clinical diagnosis of CHED was estab-
lished in all cases, and this was conﬁrmed by histologic exam-
ination which demonstrated attenuated endothelium and
thickened Descemet’s membrane. White superﬁcial nodular
corneal opacities were an interesting clinical ﬁnding and were
found to be amyloid deposits in all cases on histopathology.
These deposits resembled clinically the amyloid deposits seen
in primary gelatinous drop-like corneal dystrophy (PGDD),
which is a rare corneal dystrophy, most probably autosomal
recessive in nature. PGDD was ﬁrst described in Japan in
1914 followed by other reports (Al-Rajhi, 2000; Solomon
et al., 2008; Akiya et al., 1972). It usually presents with photo-
phobia, foreign body sensation, and decreased vision in the
second or third decades of life. PGDD has a high incidence
of recurrence after keratoplasty (Akiya et al., 1972). The amy-
loid deposition in PGDD is subepithelial as in our patients,
nevertheless, none of our patients had any recurrence after ker-
atoplasty which indicates a separate pathology.
An article from India described another ﬁve patients with
CHED and amyloid deposition. The authors attributed amy-
loid depositions to degenerative changes and stromal inﬂam-
mation and they classiﬁed amyloid as secondary in nature
based on immunohistochemical ﬁndings. None of their pa-
tients were related and the youngest patient was 8 years old
at the time of PKP (Mahmood and Teichmann, 2000). Despite
the phenotypic and histologic resemblance to the patients in
our study (especially patient 1) we assume the amyloid type
in our patients is primary rather than secondary (especially pa-
tients 2–5) for several reasons. First, we observed these depos-
its in four related patients with history of consanguinity in
which case, inheritance is considered a major role in explaining
the amyloid deposition. Second, the size and conﬁguration of
amyloid deposits is too large to accumulate as secondary amy-
loid over such a short time, since our patients were very young
at the time of surgery (patient 4 was 5 years old and patient 5
was only 3 years). Third, known local causes of secondary
amyloid deposition like spheroidal degeneration, trichiasis,
or trachoma were not observed in any of the patients. Fourth,
amyloid typing based on immunohistochemical testing may be
inconclusive or even misleading, therefore unreliable (Al-Rajhi
and Wagoner, 1997; Satoskar et al., 2007). Immunohistochem-
ical amyloid identiﬁcation utilizes immunoglobulin light chains
immunoﬂuorescence staining which is presumed to identify
amyloid AL (primary amyloid) ﬁbrils through positive reac-
tion to commercially available anti-light chain antibodies
which lack speciﬁcity by cross-reaction with amyloid AA (sec-
ondary amyloid) ﬁbrils (Satoskar et al., 2007). To obtain an
accurate amyloid typing, chemical analysis using tandem mass
spectrometry is necessary (Al-Rajhi and Wagoner, 1997). This
method of testing, which is based on proteomics technologies,
will allow direct molecular identiﬁcation of the amyloid pro-
tein and has the advantage of less tissue needed for identiﬁca-
tion compared to other means of testing (Al-Rajhi and
Wagoner, 1997; Satoskar et al., 2007). Unfortunately, this is
a new technology and no laboratory in Saudi Arabia has thecapability of conducting such testing, so running these test
on our samples was not possible.
The prognosis of penetrating keratoplasty in CHED associ-
ated with amyloid deposits is good with no recurrence of amy-
loid as observed in our patients as well as previously reported
cases in the literature (Hill et al., 1990; Mahmood and Teich-
mann, 2000). The amyloid deposition in association with
CHED dose not seem to increase future graft rejection, infec-
tion nor failure.
In summary, we have described ﬁve cases of CHED associ-
ated with presumably primary subepithelial amyloid deposi-
tion. This ﬁnding is not as rare to be associated with CHED
as previously described. We believe that this ﬁnding indicates
a new subtype of autosomal recessive CHED, however it re-
quires further chemical and genetic analysis.
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